Skip to content

Analysis of Gut Microbiome and Metabolite Characteristics in Patients with Degenerative Lumbar Spine Disease: An Observational Study

Analysis of Gut Microbiome and Metabolite Characteristics in Patients with Degenerative Lumbar Spine Disease: An Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129063
Enrollment
Unknown
Registered
2026-07-30
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intervertebral disc degeneration

Interventions

LDD group:None
Healthy control group:None

Sponsors

Chongqing Xinqiao Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for the LDD group: (1) Aged 40–75 years; (2) A definitive diagnosis of symptomatic degenerative lumbar spine disease (e.g. single- or multi-segmental lumbar disc herniation, spinal stenosis) based on clinical symptoms, physical signs and imaging (MRI/CT); Pfirrmann disc degeneration grade III or higher, a VAS score greater than 4, an ODI score greater than 60, or the presence of marked lower back pain and functional impairment; (3) Priority will be given to patients with a balanced diet, regular exercise habits, regular bowel movements, good sleep quality, and who are either not taking any medication or are taking only those that have a significant impact on degenerative lumbar spine disease, gut microbiota and lifestyle habits; (4) Voluntary participation and signing of a written informed consent form. Inclusion criteria for the HC group: (1) Age, sex and BMI matched with the LDD group (matching criteria: ±5 years, BMI ±3 kg/m^2); (2) No history of chronic low back pain or sciatica; (3) Voluntary participation and signing of a written informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion criteria for the LDD group: (1) Use of antibiotics, probiotics or systemic immunosuppressants within the past three months; (2) Concurrent major gastrointestinal diseases, such as inflammatory bowel disease or colorectal cancer; (3) Severe systemic diseases (e.g. uncontrolled diabetes, active rheumatic or autoimmune diseases, malignant tumours, severe hepatic or renal insufficiency); Exclusion criteria for the HC group: (1) Same as the exclusion criteria for the LDD group (points 1, 2 and 3); (2) Imaging studies indicate clinically significant lumbar degeneration. (4) History of lumbar spine surgery, spinal trauma, infection or tumour; (5) Pregnant or breastfeeding women.

Design outcomes

Primary

MeasureTime frame
Imaging-related indicators;;Routine blood test-related parameters;Routine stool test-related parameters;Liver and renal function-related parameters;

Countries

China

Contacts

Public ContactLiu Minghan

Chongqing Xinqiao Hospital

liuminghan@tmmu.edu.cn+86 158 2351 2096

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026